Based on the predicted gene associations from the PPI network, IL-6, MMP2, MMP9, MAPK14, SLC2A1 and FGF2 were identified as main hub genes, which are potentially involved in the treatment of RP using Gyp via an anti-oxidative stress or anti-inflammation route. This evidence concerns the gene MMP9 and retinitis pigmentosa 1.